Have your own idea? Try our Stock Screener
Argentinian (MERVAL) Pharma Industry Analysis
UpdatedAug 30, 2025
DataAggregated Company Financials
Companies2
- 7D-7.8%
- 3M-20.3%
- 1Y23.9%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 7.3%, driven by a pullback from Laboratorios RichmondC.I.F of 8.2%. Meanwhile, Instituto Rosenbusch actually outperformed within the industry, gaining 5.6% in the last week. This takes the industry's 12 month performance to a gain of 24%.
Industry Valuation and Performance
Has the Argentinian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 31 Aug 2025 | AR$97.6b | AR$104.5b | AR$9.0b | 8x | 10.8x | 0.9x |
| Tue, 29 Jul 2025 | AR$121.3b | AR$102.7b | AR$16.3b | 6x | 7.5x | 1.2x |
| Thu, 26 Jun 2025 | AR$121.2b | AR$104.7b | AR$17.4b | 5.9x | 7x | 1.2x |
| Sat, 24 May 2025 | AR$123.6b | AR$104.7b | AR$17.4b | 6.3x | 7.1x | 1.2x |
| Mon, 21 Apr 2025 | AR$121.1b | AR$100.1b | AR$22.4b | 4.9x | 5.4x | 1.2x |
| Wed, 19 Mar 2025 | AR$142.2b | AR$96.9b | AR$24.8b | 4.9x | 5.7x | 1.5x |
| Fri, 14 Feb 2025 | AR$126.8b | AR$42.6b | AR$18.2b | 6x | 7x | 3x |
| Sun, 12 Jan 2025 | AR$146.0b | AR$42.6b | AR$18.2b | 6.6x | 8x | 3.4x |
| Tue, 10 Dec 2024 | AR$140.0b | AR$42.6b | AR$18.2b | 6.6x | 7.7x | 3.3x |
| Thu, 07 Nov 2024 | AR$132.8b | AR$40.7b | AR$4.6b | 21.5x | 29.2x | 3.3x |
| Sat, 05 Oct 2024 | AR$79.0b | AR$40.7b | AR$4.6b | 12.5x | 17.4x | 1.9x |
| Mon, 02 Sep 2024 | AR$81.4b | AR$42.3b | AR$4.3b | 13.3x | 18.8x | 1.9x |
| Wed, 31 Jul 2024 | AR$80.0b | AR$41.1b | -AR$3,264,658,797.00 | 3.9x | -24.5x | 1.9x |
| Fri, 28 Jun 2024 | AR$84.1b | AR$41.1b | -AR$3,264,658,797.00 | 5.2x | -25.8x | 2x |
| Sun, 26 May 2024 | AR$87.9b | AR$41.1b | -AR$3,264,658,797.00 | 4.9x | -26.9x | 2.1x |
| Tue, 23 Apr 2024 | AR$74.8b | AR$43.6b | -AR$10,287,966,966.00 | 7.4x | -7.3x | 1.7x |
| Thu, 21 Mar 2024 | AR$71.5b | AR$9.6b | -AR$4,702,241,388.00 | 45x | -15.2x | 7.4x |
| Sat, 17 Feb 2024 | AR$88.8b | AR$9.6b | -AR$4,702,241,388.00 | 66x | -18.9x | 9.2x |
| Mon, 15 Jan 2024 | AR$65.7b | AR$10.3b | -AR$4,704,193,685.00 | 36.8x | -14x | 6.4x |
| Wed, 13 Dec 2023 | AR$64.8b | AR$10.3b | -AR$4,704,193,685.00 | 35.7x | -13.8x | 6.3x |
| Fri, 10 Nov 2023 | AR$56.2b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -22.5x | 4.3x |
| Sun, 08 Oct 2023 | AR$46.1b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -18.5x | 3.5x |
| Tue, 05 Sep 2023 | AR$48.4b | AR$18.8b | -AR$150,001,147.00 | 18.4x | -322.9x | 2.6x |
| Thu, 03 Aug 2023 | AR$43.0b | AR$18.8b | -AR$150,001,147.00 | 13.8x | -286.6x | 2.3x |
| Sat, 01 Jul 2023 | AR$42.5b | AR$18.8b | -AR$150,001,147.00 | 13.8x | -283.6x | 2.3x |
| Mon, 29 May 2023 | AR$39.9b | AR$19.1b | AR$209.1m | 128.2x | 191x | 2.1x |
| Wed, 26 Apr 2023 | AR$33.3b | AR$19.1b | AR$209.1m | 106.9x | 159.4x | 1.7x |
| Fri, 24 Mar 2023 | AR$32.0b | AR$19.1b | AR$209.1m | 102.6x | 153.1x | 1.7x |
| Sun, 19 Feb 2023 | AR$32.1b | AR$13.7b | AR$1.5b | 17.2x | 20.7x | 2.3x |
| Tue, 17 Jan 2023 | AR$33.9b | AR$13.7b | AR$1.5b | 17.5x | 21.9x | 2.5x |
| Thu, 15 Dec 2022 | AR$28.9b | AR$13.8b | AR$1.5b | 18.9x | 19.2x | 2.1x |
| Sat, 12 Nov 2022 | AR$27.0b | AR$19.6b | AR$1.4b | 19.4x | 19.8x | 1.4x |
| Mon, 10 Oct 2022 | AR$28.1b | AR$19.7b | AR$1.4b | 24.5x | 20.4x | 1.4x |
| Wed, 07 Sep 2022 | AR$24.1b | AR$17.8b | AR$987.0m | 27.7x | 24.4x | 1.3x |
Price to Earnings Ratio
24.4x
Current Industry PE
- There are only 2 companies in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 109% per year over the last three years.
- Revenues for these companies have grown 80% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Argentinian Pharma compare with similar industries?
| AR Market | -5.63% | |
| Healthcare | -7.78% | |
| Pharma | -7.78% | |
| Pharma | -7.78% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||